Sitemap
The sitemap for the Adaptimmune website is detailed below.
All News & Events:
- Adaptimmune enters into Cell Therapy Manufacturing Services Agreement with NeoStem Subsidiary, Progenitor Cell Therapy.
- Press Articles from the Life Technologies Press release
- Exclusive License with Life Technologies Corporation on Proprietary Manufacturing Process for T Cell Therapy
- Press Articles from the ASH Press release
- Preliminary Results from an Early Phase Trial of Gene Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma
- Investigators to Present Preliminary Adaptimmune’s Findings for Gene Engineered T Cells in Myeloma
- American Society of Cell and Gene Therapy
- Adaptimmune is strengthening its Board
- Opening of Pilot Clinical Trial in Synovial Sarcoma
- Opening of Phase I/II Clinical Trial for Metastatic Melanoma
- Opening of Phase I/II Clinical Trial in Multiple Myeloma
- Adaptimmune announces launch of US Subsidiary
- International Congress of Immunology
- Adaptimmune announces first ever clinical trial with engineered T cells designed to clear HIV infection
- Adaptimmune announces first ever clinical trial with engineered T cells designed to clear HIV infection
- Press Release: Adaptimmune engineers immune cells able to clear HIV – clinical trials planned
- Adaptimmune officially founded